Skip to main content
Premium Trial:

Request an Annual Quote

U.S./Finnish Diabetes Research Group Partners with Perlegen

NEW YORK, Oct. 28-Perlegen will offer its microarray-based SNP genotyping expertise to an international collaborative project that studies the genetics of type 2 diabetes, the company said today.

 

The project, which will seek for diabetes-related genes on the long arm of chromosome 6, involves researchers from the National Human Genome Research Institute, form the National Public Health Institute of Finland, the University of Southern California, and the University of Michigan.

 

This U.S.-Finnish collaboration, after nine years of research, has identified specific regions of the genome that may include genes pertinent to the disease. Working with Perlegen Chief Scientific Officer David Cox, the team will apply the company's chip-based system for high-throughput genotyping to further narrow the focus.

 

Roughly 16 million people in the United States have type 2 diabetes, according to the American Diabetes Association.The disease is thought to be influenced by both genetics and environment.

 

The company did not disclose financial specifics or rights to gene discoveries.

 

Perlegen is an Affymetrix subsidiary.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.